The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation

Amyloid

Volumn 19, Issue 2, 2012, Pages 113-117

  Ammirati, Enrico ^a   Marziliano, Nicola ^a   Vittori, Claudia ^a   Pedrotti, Patrizia ^a   Bramerio, Manuela A ^a   Motta, Valentina ^a   Orsini, Francesco ^a   Veronese, Silvio ^a   Merlini, Piera A ^a   Martinelli, Luigi ^a   Frigerio, Maria ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Amyloidosis; Heart failure; Heart transplantation; Transthyretin; Val122Ile mutation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; PREALBUMIN; STEROID;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CAUCASIAN; DISEASE COURSE; DISEASE SEVERITY; FAMILY; GENE MUTATION; HEART AMYLOIDOSIS; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINKAGE ANALYSIS; LIVER TRANSPLANTATION; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AMYLOID; AMYLOIDOSIS, FAMILIAL; CARDIOMYOPATHIES; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREALBUMIN;

EID: 84861635833     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.666509     Document Type: Article

References (13)

1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010;17:101-104.
2. Rapezzi C, Quarta CC, Riva L, Longhi S, Gallelli I, Lorenzini M, Ciliberti P, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 2010;7:398-408.
3. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203-1212.
4. Buxbaum J, Alexander A, Koziol J, Tagoe C, Fox E, Kitzman D. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Am Heart J 2010;159:864-870.
5. Yamashita T, Hamidi Asl K, Yazaki M, Benson MD. A prospective evaluation of the transthyretin Ile122 allele frequency in an African- American population. Amyloid 2005;12:127-130.
6. Gillmore JD, Booth DR, Pepys MB, Hawkins PN. Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man. Heart 1999;82:e2.
7. Hamidi Asl K, Nakamura M, Yamashita T, Benson MD. Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family. Amyloid 2001;8:263-269.
8. Afolabi I, Hamidi Asl K, Nakamura M, Jacobs P, Hendrie H, Benson MD. Transthyretin isoleucine-122 mutation in African and American blacks. Amyloid 2000;7:121-125.
9. Nichols WC, Liepnieks JJ, Snyder EL, Benson MD. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med 1991;117:175-180.
10. Barreiros AP, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Schäfers HJ, Galle PR, Otto G. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience. Liver Transpl 2010;16:314-323.
11. Dubrey SW, Burke MM, Hawkins PN, Banner NR. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant 2004;23:1142-1153.
12. Hamour IM, Lachmann HJ, Goodman HJ, Petrou M, Burke MM, Hawkins PN, Banner NR. Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. Am J Transplant 2008;8:1056-1059.
13. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, Clayton DG, McKeigue PM. Control of confounding of genetic associations in stratified populations. Am J Hum Genet 2003;72:1492-1504.